-
101
The potential of MRI radiomics based on extrapulmonary metastases in predicting EGFR mutations: a systematic review and meta-analysis
Published 2025-01-01Subjects: “…Non-small cell lung cancer…”
Get full text
Article -
102
Identification of prognostic biomarker of non-small cell lung cancer based on mitochondrial permeability transition-driven necrosis-related genes and determination of anti-tumor ef...
Published 2025-02-01Subjects: “…Non-small cell lung cancer…”
Get full text
Article -
103
The impact of PD-L1 expression status on the prognosis of ALK-positive lung cancer patients
Published 2024-01-01Subjects: “…Non-squamous non-small cell lung cancer…”
Get full text
Article -
104
Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer
Published 2025-01-01Subjects: “…Advanced non-small cell lung cancer…”
Get full text
Article -
105
Characteristics, treatment patterns, and biomarker testing of patients with advanced RET fusion-positive non-small cell lung cancer in a real-world multi-country observational stud...
Published 2025-02-01Subjects: “…RET fusion-positive non-small cell lung cancer…”
Get full text
Article -
106
The effect of baseline versus early glucocorticoid use on immune checkpoint inhibitor efficacy in patients with advanced NSCLC
Published 2025-01-01Subjects: Get full text
Article -
107
Efficacy and Safety Evaluation of Immune Checkpoint Inhibitors in Combination With Chemotherapy for Extensive Small Cell Lung Cancer: Real‐World Evidence
Published 2024-12-01Subjects: “…extensive‐stage small cell lung cancer…”
Get full text
Article -
108
Postoperative radiotherapy improves survival in completely resected non-small cell lung cancer with pathologic N2 stage IIIA and positive lymph node count greater than one: a SEER-...
Published 2025-02-01Subjects: “…non-small cell lung cancer…”
Get full text
Article -
109
-
110
CDK4/6 inhibitors promote PARP1 degradation and synergize with PARP inhibitors in non-small cell lung cancer
Published 2025-02-01Subjects: Get full text
Article -
111
Updated Bayesian network meta-analysis on the efficacy and safety of PD−1 versus PD−L1 inhibitors in first−line treatment with chemotherapy for extensive−stage small-cell lung canc...
Published 2025-01-01Subjects: “…extensive-stage small-cell lung cancer…”
Get full text
Article -
112
Monitoring of Circulating Tumor DNA and Indication of De-Escalation Adjuvant Targeted Therapy for EGFR-Mutated NSCLC After Complete Resection
Published 2025-01-01Subjects: “…Non–small cell lung cancer…”
Get full text
Article -
113
Microwave Ablation Combined with Flt3L Provokes Tumor‐Specific Memory CD8+ T Cells‐Mediated Antitumor Immunity in Response to PD‐1 Blockade
Published 2025-01-01Subjects: Get full text
Article -
114
Intervening Non-Small-Cell Lung Cancer Progression by Cell Membrane Coated Platycodin D via Regulating Hsa-miR-1246/FUT9/GSK3β Pathway
Published 2025-02-01Subjects: “…non-small cell lung cancer…”
Get full text
Article -
115
Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis
Published 2025-02-01Subjects: “…Non-small cell lung cancer (NSCLC)…”
Get full text
Article -
116
Lower respiratory tract microbiome dysbiosis impairs clinical responses to immune checkpoint blockade in advanced non‐small‐cell lung cancer
Published 2025-01-01Subjects: “…advanced non‐small‐cell lung cancer…”
Get full text
Article -
117
-
118
Composition of the sputum bacterial microbiome of patients with different pathomorphological forms of non-small-cell lung cancer
Published 2024-04-01Subjects: “…non-small cell lung cancer…”
Get full text
Article -
119
Editorial: Insights in clinical and translational physiology: 2023
Published 2025-01-01Subjects: “…non-small-cell lung cancer (NLSCLC)…”
Get full text
Article -
120